ZAQS.ORG

Stocks started the week with promise but ended in despair. Our take on the big reversal

23 hours ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

1 day ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

2 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

2 days ago

West Pharma: More than a GLP-1 play. The case for further upside

2 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

2 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

2 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

3 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

3 days ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

4 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

5 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

5 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

8 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

9 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

10 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

10 days ago

Sickle cell gene therapies offer new hope, but access remains a major challenge

16 days ago

Here's our monthly update on our 32 stocks, including 2 more names to buy

16 days ago

Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time

16 days ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

17 days ago

Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost

17 days ago

UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs

18 days ago

Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock

19 days ago

Jim Cramer week ahead: Bank earnings, ASML and TSMC

19 days ago

For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come

23 days ago

Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday

24 days ago

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

25 days ago

Jim Cramer says Grail can run higher as FDA decision on Galleri nears

25 days ago

Russian lab worker's suspected plague death leaves experts puzzled

26 days ago

Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk

26 days ago

AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos

26 days ago

Russian lab worker dies amid plague reports. Here's what we know

26 days ago